AAAHC’s benchmarking study is based on clinical studies of YAG laser posterior capsulotomy surgeries between January and June 2018. The study includes 25 organizations with a combined 15,788 YAG laser ...
(RTTNews) - Innovent Biologics Inc. (IVBXF.OB) announced that the New Drug Application or NDA for ipilimumab injection (anti-CTLA-4 monoclonal antibody) has been accepted by the Center for Drug ...
Pharmaceutical Technology on MSN
Innovent receives NMPA approval for Tabosun colon cancer treatment
Innovent Biologics has received China’s National Medical Products Administration (NMPA) approval for the New Drug Application ...
NMPA Accepts NDA and Grants Priority Review Designation to Innovent's Ipilimumab Injection, China's First Domestic CTLA-4 Inhibitor, in Combination with Sintilimab as Neoadjuvant Treatment for Colon ...
Are you a member of an institution such as a university or hospital?Learn more about Institutional Access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback